Published in AIDS Res Hum Retroviruses on September 01, 2008
Human leukocyte antigens and HIV type 1 viral load in early and chronic infection: predominance of evolving relationships. PLoS One (2010) 0.98
Human leukocyte antigen variants B*44 and B*57 are consistently favorable during two distinct phases of primary HIV-1 infection in sub-Saharan Africans with several viral subtypes. J Virol (2011) 0.94
Antibody neutralization and escape by HIV-1. Nature (2003) 21.48
Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat Med (2000) 11.90
Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding. J Virol (1995) 5.43
Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160. Nature (1990) 5.33
Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial. J Infect Dis (2005) 5.14
Prevention of HIV-1 infection in chimpanzees by gp120 V3 domain-specific monoclonal antibody. Nature (1992) 4.75
Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection. J Virol (2007) 4.13
Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study. J Infect Dis (2000) 3.73
Cryptic nature of envelope V3 region epitopes protects primary monocytotropic human immunodeficiency virus type 1 from antibody neutralization. J Virol (1994) 3.70
Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage. J Virol (1998) 2.83
Autologous and heterologous neutralizing antibody responses following initial seroconversion in human immunodeficiency virus type 1-infected individuals. J Virol (1997) 2.75
Complete protection of neonatal rhesus macaques against oral exposure to pathogenic simian-human immunodeficiency virus by human anti-HIV monoclonal antibodies. J Infect Dis (2004) 2.47
Human monoclonal antibodies specific for conformation-sensitive epitopes of V3 neutralize human immunodeficiency virus type 1 primary isolates from various clades. J Virol (2002) 2.43
Evidence for potent autologous neutralizing antibody titers and compact envelopes in early infection with subtype C human immunodeficiency virus type 1. J Virol (2006) 2.41
The c3-v4 region is a major target of autologous neutralizing antibodies in human immunodeficiency virus type 1 subtype C infection. J Virol (2007) 2.29
Regional clustering of shared neutralization determinants on primary isolates of clade C human immunodeficiency virus type 1 from South Africa. J Virol (2002) 1.97
Conserved and exposed epitopes on intact, native, primary human immunodeficiency virus type 1 virions of group M. J Virol (2000) 1.96
Challenge of chimpanzees (Pan troglodytes) immunized with human immunodeficiency virus envelope glycoprotein gp120. J Virol (1989) 1.61
Development of the antibody response in acute HIV-1 infection. AIDS (2004) 1.54
HIV-specific cellular and humoral immune responses in primary HIV infection. AIDS Res Hum Retroviruses (1996) 1.51
A genetic analysis of HIV-1 from Punjab, India reveals the presence of multiple variants. AIDS (1995) 1.38
Transmission of genetically diverse strains of HIV-1 in Pune, India. Indian J Med Res (1998) 1.26
Kinetics of appearance of neutralizing antibodies in 12 patients with primary or recent HIV-1 infection and relationship with plasma and cellular viral loads. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.25
Viremia control despite escape from a rapid and potent autologous neutralizing antibody response after therapy cessation in an HIV-1-infected individual. J Immunol (2003) 1.19
Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef. J Infect Dis (2005) 1.13
HIV-1 neutralizing antibodies: how full is the bottle? Nat Med (1999) 1.09
Human immunodeficiency virus (HIV)-positive sera obtained shortly after seroconversion neutralize autologous HIV type 1 isolates on primary macrophages but not on lymphocytes. J Virol (2000) 1.01
Appearance of autologous neutralizing antibody correlates with reduction in virus load and phenotype switch during primary infection with human immunodeficiency virus type 1. J Infect Dis (1997) 1.01
Frequent and early HIV-1MN neutralizing capacity in sera from Dutch HIV-1 seroconverters is related to antibody reactivity to peptides from the gp120 V3 domain. AIDS Res Hum Retroviruses (1994) 0.98
Development of a neutralizing antibody response during acute primary human immunodeficiency virus type 1 infection and the emergence of antigenic variants. J Virol (1998) 0.97
The evolutionary adaptation of HIV-1 to specific immunity. Curr HIV Res (2003) 0.85
gp120 sequences from HIV type 1 subtype C early seroconverters in India. AIDS Res Hum Retroviruses (2004) 0.82
Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings. PLoS Med (2012) 2.40
Nevirapine resistance and breast-milk HIV transmission: effects of single and extended-dose nevirapine prophylaxis in subtype C HIV-infected infants. PLoS One (2009) 1.70
Modification of medical outcome study (MOS) instrument for quality of life assessment & its validation in HIV infected individuals in India. Indian J Med Res (2005) 1.56
Maternal tuberculosis: a risk factor for mother-to-child transmission of human immunodeficiency virus. J Infect Dis (2011) 1.50
Modeling the optimum duration of antibiotic prophylaxis in an anthrax outbreak. Proc Natl Acad Sci U S A (2003) 1.41
Utility of the point of care CD4 analyzer, PIMA, to enumerate CD4 counts in the field settings in India. AIDS Res Ther (2012) 1.35
Correlates and trend of HIV prevalence among female sex workers attending sexually transmitted disease clinics in Pune, India (1993-2002). J Acquir Immune Defic Syndr (2006) 1.34
Incidence of common opportunistic infections in HIV-infected individuals in Pune, India: analysis by stages of immunosuppression represented by CD4 counts. Int J Infect Dis (2008) 1.28
Cervical squamous intra-epithelial changes and human papillomavirus infection in women infected with human immunodeficiency virus in Pune, India. J Med Virol (2005) 1.25
Condom use and prevalence of syphilis and HIV among female sex workers in Andhra Pradesh, India - following a large-scale HIV prevention intervention. BMC Public Health (2011) 1.22
Drug resistance pattern of Mycobacterium tuberculosis in seropositive and seronegative HIV-TB patients in Pune, India. Indian J Med Res (2005) 1.21
Comparisons of anemia, thrombocytopenia, and neutropenia at initiation of HIV antiretroviral therapy in Africa, Asia, and the Americas. Int J Infect Dis (2010) 1.20
Correlates of HIV vaccine trial participation: an Indian perspective. Vaccine (2005) 1.19
HIV infection in India: epidemiology, molecular epidemiology and pathogenesis. J Biosci (2008) 1.10
Public health vaccination policies for containing an anthrax outbreak. Nature (2004) 1.09
Initial virologic response and HIV drug resistance among HIV-infected individuals initiating first-line antiretroviral therapy at 2 clinics in Chennai and Mumbai, India. Clin Infect Dis (2012) 1.06
Mortality in HIV infected individuals in Pune, India. Indian J Med Res (2011) 1.04
Nurses' health education program in India increases HIV knowledge and reduces fear. J Assoc Nurses AIDS Care (2007) 1.03
Assessment of quality of life among HIV-infected persons in Pune, India. Qual Life Res (2005) 1.03
A phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C adeno-associated virus vaccine. AIDS Res Hum Retroviruses (2008) 1.01
India's new policy to protect research participants. BMJ (2013) 1.01
One-, two-, and three-class resistance among HIV-infected patients on antiretroviral therapy in private care clinics: Mumbai, India. AIDS Res Hum Retroviruses (2010) 1.01
Correlates of anxiety and depression among HIV test-seekers at a Voluntary Counseling and Testing facility in Pune, India. Qual Life Res (2006) 1.00
An exploration of elevated HIV and STI risk among male sex workers from India. BMC Public Health (2013) 0.97
A review on peripheral blood CD4+ T lymphocyte counts in healthy adult Indians. Indian J Med Res (2010) 0.97
A multinational study of neurological performance in antiretroviral therapy-naïve HIV-1-infected persons in diverse resource-constrained settings. J Neurovirol (2011) 0.96
High rates of all-cause and gastroenteritis-related hospitalization morbidity and mortality among HIV-exposed Indian infants. BMC Infect Dis (2011) 0.96
Safety and immunogenicity of DNA and MVA HIV-1 subtype C vaccine prime-boost regimens: a phase I randomised Trial in HIV-uninfected Indian volunteers. PLoS One (2013) 0.95
Situational analysis of teaching and learning of medicine and nursing students at Makerere University College of Health Sciences. BMC Int Health Hum Rights (2011) 0.95
Evidence of a novel B/C recombinant exhibiting unique breakpoints of near full-length HIV type 1 genome from Northeastern India. AIDS Res Hum Retroviruses (2008) 0.95
Feasibility and Acceptability of Smartphone-Based Ecological Momentary Assessment of Alcohol Use Among African American Men Who Have Sex With Men in Baltimore. JMIR Mhealth Uhealth (2015) 0.94
Consistent condom use with regular, paying, and casual male partners and associated factors among men who have sex with men in Tamil Nadu, India: findings from an assessment of a large-scale HIV prevention program. BMC Public Health (2013) 0.93
Characterization of B/C recombinants of near full-length HIV type 1 from northeastern India with mosaics identical to ARE195FL but with a different ancestral origin. AIDS Res Hum Retroviruses (2008) 0.92
Research capacity-building program for clinicians and staff at a community-based HIV clinic in Uganda: A pre/post evaluation. J Assoc Nurses AIDS Care (2012) 0.92
Guidelines for use of antiretroviral therapy for HIV infected individuals in India (ART guidelines 2008). J Assoc Physicians India (2008) 0.90
Full-length gag sequences of HIV type 1 subtype C recent seroconverters from Pune, India. AIDS Res Hum Retroviruses (2004) 0.89
Safety & immunogenicity of tgAAC09, a recombinant adeno-associated virus type 2 HIV-1 subtype C vaccine in India. Indian J Med Res (2010) 0.87
HIV testing behaviors among Latinos in Baltimore City. J Immigr Minor Health (2012) 0.87
A consortium approach to competency-based undergraduate medical education in Uganda: process, opportunities and challenges. Educ Health (Abingdon) (2014) 0.86
High rates of reinfection and incidence of bacterial sexually transmitted infections in a cohort of female sex workers from two Indian cities: need for different STI control strategies? Sex Transm Infect (2012) 0.86
Pattern of linkage and retention in HIV care continuum among patients attending referral HIV care clinic in private sector in India. AIDS Care (2015) 0.86
Molecular characterization of unique intersubtype HIV type 1 A1/C recombinant strain circulating in Pune, India. AIDS Res Hum Retroviruses (2013) 0.85
Evaluation of a diagnostic algorithm for sputum smear-negative pulmonary tuberculosis in HIV-infected adults. J Acquir Immune Defic Syndr (2013) 0.84
Use of first line antiretroviral therapy from a free ART programme clinic in Pune, India - a preliminary report. Indian J Med Res (2013) 0.84
Short communication: HIV antigen-specific reactivation of HIV infection from cellular reservoirs: implications in the settings of therapeutic vaccinations. AIDS Res Hum Retroviruses (2011) 0.84
Sexually transmitted infections and risk behaviors among transgender persons (Hijras) of Pune, India. J Acquir Immune Defic Syndr (2012) 0.83
Mother-to-child transmission of HIV among women who chose not to exclusively breastfeed their infants in Pune, India. Indian J Med Res (2007) 0.83
Community preparedness for HIV vaccine trials in the Democratic Republic of Congo. Cult Health Sex (2006) 0.83
Role of community group exposure in reducing sexually transmitted infection-related risk among female sex workers in India. PLoS One (2013) 0.83
HIV-1 clade C env clones obtained from an Indian patient exhibiting expanded coreceptor tropism are presented with naturally occurring unusual amino acid substitutions in V3 loop. Virus Res (2009) 0.83
Determinants of common mental disorder, alcohol use disorder and cognitive morbidity among people coming for HIV testing in Goa, India. Trop Med Int Health (2014) 0.83
Heparin and EDTA anticoagulants differentially affect the plasma cytokine levels in humans. Scand J Clin Lab Invest (2013) 0.83
Increased HIV prevention program coverage and decline in HIV prevalence among female sex workers in south India. Sex Transm Dis (2014) 0.83
Limited evolution in the HIV type 1 pol region among acute seroconverters in Pune, India. AIDS Res Hum Retroviruses (2005) 0.82
A single amino acid substitution in the C4 region in gp120 confers enhanced neutralization of HIV-1 by modulating CD4 binding sites and V3 loop. Virology (2011) 0.81
Symptoms of common mental disorder and cognitive associations with seropositivity among a cohort of people coming for testing for HIV/AIDS in Goa, India: a cross-sectional survey. BMC Public Health (2013) 0.81
Genetic analysis of Indian HIV-1 nef: subtyping, variability and implications. Microbes Infect (2004) 0.80
Intranasal administration of peptide antigens of HIV with mucosal adjuvant CpG ODN coentrapped in microparticles enhances the mucosal and systemic immune responses. Int Immunopharmacol (2009) 0.80
Association of plasma viremia with HIV-1 RNA levels in cervicovaginal lavage secretions in HIV-1 seropositive ART naïve women from Pune, India. J Clin Virol (2013) 0.80
The other side of the bridge: exploring the sexual relationships of men who have sex with men and their female partners in Mumbai, India. Cult Health Sex (2014) 0.80
Correlates of sex initiation among school going adolescents in Pune, India. Indian J Pediatr (2013) 0.79
Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results From the HIV Prevention Trials Network 052 Trial. J Acquir Immune Defic Syndr (2016) 0.79
Vitamin D deficiency is common among HIV-infected breastfeeding mothers in Pune, India, but is not associated with mother-to-child HIV transmission. HIV Clin Trials (2012) 0.79
Psychological predictors for attendance of post-HIV test counselling and linkage to care: the Umeed cohort study in Goa, India. BMC Psychiatry (2014) 0.79
Predictors of mortality in hospitalized children with pandemic H1N1 influenza 2009 in Pune, India. Indian J Pediatr (2011) 0.79
Characterization of circulating HIV type 1 env genes in plasma of two antiretroviral-naive slow progressing patients with broad neutralizing antibody response with evidence of recombination. AIDS Res Hum Retroviruses (2011) 0.79
Local differences in human immunodeficiency virus prevalence: a comparison of social venue patrons, antenatal patients, and sexually transmitted infection patients in eastern kinshasa. Sex Transm Dis (2009) 0.78
Expansion of defective NK cells in early HIV type 1C infection: a consequence of reduced CD161 expression. AIDS Res Hum Retroviruses (2011) 0.77
In vitro sensitization of T cells with DC-associated/delivered HIV constructs can induce a polyfunctional CTL response, memory T-cell response, and virus suppression. Viral Immunol (2012) 0.77
Indian primary HIV-2 isolates and relationship between V3 genotype, biological phenotype and coreceptor usage. Virology (2005) 0.77